Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideto Tamura

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Tohoku Journal of Experimental Medicine|September 13, 2019
Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple MyelomaKeita Iwaki, Tohru Fujiwara, Takako Ito, et al.
Nature Medicine|July 2, 2002
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionHaidong Dong, Scott E Strome, Diva R Salomao, et al.
Cancer Research|October 16, 2003
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinomaScott E Strome, Haidong Dong, Hideto Tamura, et al.
Blood|October 24, 2002
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndromeKiyoyuki Ogata, Kyoko Nakamura, Norio Yokose, et al.
Leukemia Research|December 25, 2009
Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromesHideto Tamura, Kazuo Dan, Norio Yokose, et al.
Leukemia Research|June 12, 2012
Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation studyKiyoyuki Ogata, Keiji Kakumoto, Akira Matsuda, et al.
International Journal of Hematology|December 17, 2025
Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 studyShigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, et al.
Experimental Hematology|February 16, 2023
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myelomaRyosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, et al.
Haematologica|February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studyMatteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
International Journal of Clinical Oncology|July 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapseHiroshi Yasui, Masayuki Kobayashi, Kota Sato, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Tohoku Journal of Experimental Medicine|September 13, 2019
Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple MyelomaKeita Iwaki, Tohru Fujiwara, Takako Ito, et al.
Nature Medicine|July 2, 2002
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionHaidong Dong, Scott E Strome, Diva R Salomao, et al.
Cancer Research|October 16, 2003
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinomaScott E Strome, Haidong Dong, Hideto Tamura, et al.
Blood|October 24, 2002
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndromeKiyoyuki Ogata, Kyoko Nakamura, Norio Yokose, et al.
Leukemia Research|December 25, 2009
Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromesHideto Tamura, Kazuo Dan, Norio Yokose, et al.
Leukemia Research|June 12, 2012
Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation studyKiyoyuki Ogata, Keiji Kakumoto, Akira Matsuda, et al.
International Journal of Hematology|December 17, 2025
Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 studyShigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, et al.
Experimental Hematology|February 16, 2023
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myelomaRyosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, et al.
Haematologica|February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studyMatteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
International Journal of Clinical Oncology|July 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapseHiroshi Yasui, Masayuki Kobayashi, Kota Sato, et al.
Pageof 7